Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteconformis.com
Twitter@ConforMIS
CategoryMedical
Phone(781) 345-9001
Employees
Founded2004
DescriptionMedical Device Company

Offices

Headquarters
2 Fourth Ave.
Burlington, MA, 01803
USA

People

CEO, Founder, Chairman of the Board
Chief Financial Officer
Vice President, Marketing
Vice President, Regulatory and Quality Affairs
Senior Vice President, R&D
Senior Vice President, Knee Implant Engineering
Senior Vice President, Intellectual Property & General Counsel
Senior Vice President, Sales

Funding

TOTAL $219M
FUNDING TOTAL $219M
Series D, 8/2009
Aeris Capital
$50M
Grant, 7/2011
$1.4M
Series E, 8/2013
Sovereign Wealth Funds
Government Investment Funds
$168M

Competitors

Tags

ConforMIS

ConforMIS has developed the only line of personalized, partial knee resurfacing implants to treat knee osteoarthritis, one of the most common conditions facing our aging population.

ConforMIS is a privately held medical device company based in Massachusetts. It was founded in 2004 to provide dramatic advancements in patient care by utilizing imaging technology to create personalized, patient-specific implants and instrumentation.

ConforMIS transforms traditional CT and MRI data into patient-specific implants and instrumentation employing two related ‘image-to-implant’ technology platforms. Both platforms are supported by proprietary, intellectual property consisting of more than 250 patents and pending patent applications that span imaging software, image processing, implant design, surgical techniques and orthopedic instrumentation. The technology and patent portfolio is applicable to all major joint systems.

To date, ConforMIS has developed a comprehensive line of minimally traumatic implant solutions to address all stages of knee osteoarthritis, the most common reason for knee replacement surgery. Each of these devices has been cleared for marketing by the US Food and Drug Administration. Certain ConforMIS implants have also received CE Marking for the European region.

Recent Milestones

  • Dollar
    ConforMIS received $168M in Series E funding. (8/2/13)
    Posted 8/4/13 at 8:24pm via finsmes.com
  • Dollar
    ConforMIS received $1.4M in Grant funding. (7/12/11)
    Posted 7/12/11 at 7:50am via masshightech.com
  • Check
    ConforMIS — has received 510k clearance from the U.S. Food and Drug Administration to commercially market its iTotal CR Knee Replacement System (2/3/11)
    Posted 2/7/11 at 5:28am via masshightech.com
  • Dollar
    ConforMIS received $50M in Series D funding. (8/10/09)
    Posted 8/11/09 at 12:52pm via onbiovc.com
  • Check
    ConforMIS added David Cerveny as Senior Vice President, Intellectual Property & General Counsel. (10/1/08)
    Posted 11/9/09 at 12:17pm
  • Check
    ConforMIS added Philipp Lang as CEO, Founder, Chairman of the Board. (1/1/04)
    Posted 11/9/09 at 12:15pm
  • Check
    ConforMIS added John Slamin as Senior Vice President, Knee Implant Engineering.
    Posted 11/9/09 at 12:17pm

Videos

Screenshots

ConforMIS screenshot
Above: Homepage
Uploaded: 8/5/13

Products

iDuoâ„¢ Bicompartmental Knee Resurfacing Device
iFormaâ„¢ Knee Interpositional Device
iTotalâ„¢ Tricompartmental Knee Resurfacing Device
iUniâ„¢ Unicompartmental Knee Resurfacing Device

Sources

  1. ConforMIS, Inc.: Series D $50M (onbiovc.com) [edit]
  2. ConforMIS scores $1.4M MassDevelopment loan (masshightech.com) [edit]
  3. ConforMIS raises $167.7m Series E financing (finsmes.com) [edit]
  4. ConforMIS knee replacement tech get FDA marketing nod (masshightech.com) [edit]
Edit This Page
Last Edited 2/20/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy